Details for 2018730161
Up to date per 02.04.2026
Actions
Details for 2018730161
Granted/Registered
European Patent
11.03.2020 A
18.10.2023 B1
01.05.2017
US
201762492947 P
29.07.2017
US
201762538670 P
23.08.2017
US
201762549390 P
01.11.2017
US
201762580433 P
08.12.2017
US
201762596753 P
A61K 35/17 20150101AFI20181109BHEP
Owner
Juno Therapeutics, Inc.400 Dexter Avenue North, Suite 1200 Seattle, WA 98109US
Representative
Representative
Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT
Inventor
PORTS, Michaelc/o Juno Therapeutics Inc. 400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
WORKS, Melissac/o Juno Therapeutics Inc. 400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
BATUREVYCH, Oleksandr400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
SALMON, Ruth400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
HAUSE, Ronald, James, Jr.400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
JOHNSTONE, Timothy, G.400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
KUGLER, David, G.400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
JONES, Jon400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
SONI, Neha400 Dexter Ave. N Suite 1200 Seattle, WA 98109US
Information about Fees